BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22623896)

  • 1. SPECT and PET imaging of meningiomas.
    Valotassiou V; Leondi A; Angelidis G; Psimadas D; Georgoulias P
    ScientificWorldJournal; 2012; 2012():412580. PubMed ID: 22623896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
    Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
    J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.
    Ivanidze J; Roytman M; Lin E; Magge RS; Pisapia DJ; Liechty B; Karakatsanis N; Ramakrishna R; Knisely J; Schwartz TH; Osborne JR; Pannullo SC
    J Neuroimaging; 2019 Sep; 29(5):650-656. PubMed ID: 31107591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in the recurrence of meningiomas by combining somatostatin receptor scintigraphy of (99m)Tc-HYNIC-octreotide SPECT/CT and radio guidance with a hand-held γ-probe during surgery.
    Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
    Nucl Med Commun; 2013 Mar; 34(3):249-53. PubMed ID: 23276828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
    Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas.
    Nathoo N; Ugokwe K; Chang AS; Li L; Ross J; Suh JH; Vogelbaum MA; Barnett GH
    J Neurooncol; 2007 Jan; 81(2):167-74. PubMed ID: 16850106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
    Xiangsong Z; Xingchong S; Chang Y; Xiaoyan W; Zhifeng C
    Clin Nucl Med; 2011 Nov; 36(11):1003-6. PubMed ID: 21975388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
    Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
    J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.
    Nyuyki F; Plotkin M; Graf R; Michel R; Steffen I; Denecke T; Geworski L; Fahdt D; Brenner W; Wurm R
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):310-8. PubMed ID: 19763565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
    Bénard F; Romsa J; Hustinx R
    Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor-2 negative meningioma: pathologic correlation and imaging implications.
    Roytman M; Pisapia DJ; Liechty B; Lin E; Skafida M; Magge RS; Osborne JR; Pannullo SC; Knisely JPS; Ramakrishna R; Ivanidze J
    Clin Imaging; 2020 Oct; 66():18-22. PubMed ID: 32442855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diagnostic value of 68 Ga-DOTATOC PET/MRI and standalone MRI for the detection of intracranial meningiomas.
    Einhellig HC; Siebert E; Bauknecht HC; Tietze A; Graef J; Furth C; Schulze D; Miszczuk M; Bohner G; Schatka I; Makowski MR
    Sci Rep; 2021 Apr; 11(1):9064. PubMed ID: 33907204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy.
    Graf R; Nyuyki F; Steffen IG; Michel R; Fahdt D; Wust P; Brenner W; Budach V; Wurm R; Plotkin M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):68-73. PubMed ID: 22575489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
    Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
    Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor imaging in intracranial tumours.
    Schmidt M; Scheidhauer K; Luyken C; Voth E; Hildebrandt G; Klug N; Schicha H
    Eur J Nucl Med; 1998 Jul; 25(7):675-86. PubMed ID: 9662588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial collision tumor mimicking an octreotide-SPECT positive and FDG-PET negative meningioma.
    Chahlavi A; Staugaitis SM; Yahya R; Vogelbaum MA
    J Clin Neurosci; 2005 Aug; 12(6):720-3. PubMed ID: 16115558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
    Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between 99mTc-HYNIC-octreotide SPECT/CT somatostatin receptor scintigraphy and pathological grading of meningioma.
    Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
    J Neurooncol; 2013 Jul; 113(3):519-26. PubMed ID: 23657621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
    Tomura N; Saginoya T; Goto H
    J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.